Rhythm Pharmaceuticals Inc (RYTM.OQ)
RYTM.OQ on NASDAQ Stock Exchange Global Market
28.71USD
16 Nov 2018
28.71USD
16 Nov 2018
Change (% chg)
$1.26 (+4.59%)
$1.26 (+4.59%)
Prev Close
$27.45
$27.45
Open
$27.31
$27.31
Day's High
$28.74
$28.74
Day's Low
$26.84
$26.84
Volume
45,987
45,987
Avg. Vol
56,243
56,243
52-wk High
$37.23
$37.23
52-wk Low
$16.89
$16.89
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.00 | -0.516 |
| Jun '18 | 0.00 | -0.515 | |
| Mar '18 | 0.00 | -0.603 | |
| FY 2017 | Dec '17 | 0.00 | -0.410 |
| Sep '17 | 0.00 | -0.445 | |
| Jun '17 | 0.00 | -0.312 | |
| Mar '17 | 0.00 | -0.293 | |
| FY 2016 | Dec '16 | 0.00 | -1.132 |
| Sep '16 | 0.00 | -0.280 | |
| Jun '16 | 0.00 | -0.254 | |
| Mar '16 | 0.00 | -0.241 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 3 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Mar-19 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 3 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 5 | 0.05 | 0.25 | 0.00 | 0.21 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 3 | -0.61 | -0.53 | -0.66 | -0.88 |
| Quarter Ending Mar-19 | 1 | -0.61 | -0.61 | -0.61 | -- |
| Year Ending Dec-18 | 3 | -2.25 | -2.15 | -2.30 | -2.19 |
| Year Ending Dec-19 | 5 | -2.63 | -1.75 | -3.66 | -2.94 |
| LT Growth Rate (%) | 1 | 20.70 | 20.70 | 20.70 | -9.90 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 79.36 | 29.34 | |
| P/E High - Last 5 Yrs. | -- | 265.87 | 45.80 | |
| P/E Low - Last 5 Yrs. | -- | 84.08 | 25.31 | |
| Beta | -- | 0.73 | 0.91 | |
| Price to Sales (TTM) | -- | 217.51 | 20.58 | |
| Price to Book (MRQ) | 3.63 | 16.40 | 4.23 | |
| Price to Tangible Book (MRQ) | 3.63 | 20.76 | 12.86 | |
| Price to Cash Flow (TTM) | -- | 48.38 | 21.19 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.42 | 1.65 | |
| Dividend Yield - 5 Year Avg | -- | 0.23 | 1.43 | |
| Dividend 5 Year Growth Rate | -- | 3.73 | -8.12 | |
| Payout Ratio(TTM) | -- | 7.92 | 43.70 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 147.95 | 6.76 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 61.16 | 5.37 | |
| Sales - 5 Yr. Growth Rate | -- | 22.11 | 7.50 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -16.05 | 79.14 | 28.07 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -45.39 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 20.47 | 7.61 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 34.50 | 8.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 3.42 | 2.60 |
| Current Ratio (MRQ) | 35.44 | 6.52 | 3.62 |
| LT Debt to Equity (MRQ) | 0.00 | 18.23 | 9.93 |
| Total Debt to Equity (MRQ) | 0.00 | 24.16 | 13.84 |
| Interest Coverage (TTM) | -- | -167.48 | 35.65 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 30.41 | 53.45 | |
| Gross Margin - 5 Yr. Avg. | -- | 47.56 | 52.35 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -157.21 | 16.19 | |
| Operating Margin (TTM) | -- | -1,764.99 | -12.21 | |
| Operating Margin - 5 Yr. Avg. | -- | -170.35 | 11.73 | |
| Pre-Tax Margin (TTM) | -- | -1,697.68 | -10.76 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -173.02 | 12.03 | |
| Net Profit Margin (TTM) | -- | -1,693.54 | -14.16 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -173.38 | 8.29 | |
| Effective Tax Rate (TTM) | -- | 14.72 | 21.78 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 19.72 | 24.36 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 0 | 24,455,811 | 843,940,439 | |
| Net Income/Employee (TTM) | -2,272,616 | -3,607,800 | 98,316,310 | |
| Receivable Turnover (TTM) | -- | 8.35 | 5.42 | |
| Inventory Turnover (TTM) | -- | 2.90 | 4.00 | |
| Asset Turnover (TTM) | 0.00 | 0.48 | 0.91 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -37.81 | -0.72 | 10.84 | |
| Return on Assets - 5 Yr. Avg. | -- | 2.40 | 11.60 | |
| Return on Investment (TTM) | -39.49 | -0.30 | 13.58 | |
| Return on Investment - 5 Yr. Avg. | -- | 2.31 | 14.86 | |
| Return on Equity (TTM) | -54.36 | -2.98 | 15.11 | |
| Return on Equity - 5 Yr. Avg. | -- | -1.50 | 16.02 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -150.29 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Rhythm Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 1.10 | 4.36 | 79 | 91 |
| 13 Week | -4.18 | -0.03 | 67 | 93 |
| 26 Week | -4.69 | -5.07 | 67 | 91 |
| 52 Week | 11.70 | 6.07 | 69 | 98 |
| YTD | -2.13 | -3.88 | 63 | 91 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 91.86% |
| # of Holders: | 123 |
| Total Shares Held: | 31,610,658 |
| 3 Mo. Net Change: | 203,113 |
| # New Positions: | 23 |
| # Closed Positions: | 18 |
| # Increased Positions: | 77 |
| # Reduced Positions: | 44 |
| # Net Buyers: | 33 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.